Overnight variations in IL-6 in synovial fluid and plasma in patients with active rheumatoid arthritis

International Journal of Clinical Rheumatology

Volumn 5, Issue 5, 2010, Pages 593-600

  Perry, Mark G ^a   Jessop, David S ^b   Hunt, Linda P ^c   Sharif, Mohammed ^c   Kirwan, John R ^c  

^a PLYMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

cortisol; cytokines; IL 1b; IL 6; pathogenesis; rheumatoid arthritis; synovial fluid; TNF

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; JOINT EFFUSION; KNEE DISEASE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

EID: 77958071355     PISSN: 17584272     EISSN: None     Source Type: Journal    
DOI: 10.2217/ijr.10.51     Document Type: Article

References (34)

1. Harkness JA, Richter MB, Panayi GS et al.: Circadian variation in disease activity in rheumatoid arthritis. Br. Med. J. (Clin. Res. Ed.) 284, 551-1544 (1982).
2. Wilder RL: Neuroendocrine-immune system interactions and autoimmunity. Ann. Rev. Immunol. 13, 307-338 (1995).
3. Lettesjo H, Nordstrom E, Strom H et al.: Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand. J. Immunol. 48, 286-292 (1998). (Pubitemid 28416972)
4. Bertazzolo N, Punzi L, Stefani MP et al.: Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions 41, 90-92 (1994).
5. Westacott CI, Whicher JT, Barnes IC et al.: Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann. Rheum. Dis. 49, 676-681 (1990).
6. Saxne T, Palladino MA Jr, Heinegard D et al.: Detection of tumor necrosis factor-a but not tumor necrosis factor-b in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 31, 1041-1045 (1988).
7. Swaak AJ, van Rooyen A, Nieuwenhuis E, Aarden LA: Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand. J. Rheumatol. 17, 469-474 (1988).
8. Houssiau FA, Devogelaer JP, Van Damme J et al.: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31, 784-788 (1988).
9. Hovdenes J, Kvien TK, Hovdenes AB: IL-6 in synovial fluids, plasma and supernatants from cultured cells of patients with rheumatoid arthritis and other inflammatory arthritides. Scand. J. Rheumatol. 19, 177-182 (1990).
10. Usón J, Balsa A, Pascual-Salcedo D et al.: Soluble interleukin-6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies. J. Rheumatol. 24, 2069-2075 (1997).
11. Sacerdote P, Carrabba M, Galante A et al.: Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: Effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen. Inflamm. Res. 44, 486-490 (1995).
12. Sack U, Kinne RW, Marx T et al.: Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol. Int. 13, 45-51 (1993).
13. Holt I, Cooper RG, Hopkins SJ: Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. Eur. J. Clin. Invest. 21, 479-484 (1991).
14. Tetta C, Camussi G, Modena V et al.: Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Ann. Rheum. Dis. 49, 665-667 (1990).
15. Steiner G, Tohidast-Akrad M, Witzmann G et al.: Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology (Oxford) 38, 202-213 (1999).
16. Holt I, Cooper RG, Denton J et al.: Cytokine inter-relationships and their association with disease activity in arthritis. Br. J. Rheumatol. 31, 725-733 (1992).
17. Fong KY, Boey ML, Koh WH, Feng PH: Cytokine concentrations in the synovial fluid and plasma of rheumatoid arthritis patients: Correlation with bony erosions. Clin. Exp. Rheumatol. 12, 55-58 (1994).
18. Nordahl S, Alstergren P, Eliasson S, Kopp S: Interleukin-1b in plasma and synovial fluid in relation to radiographic changes in arthritic temporomandibular joints. Eur. J. Oral. Sci. 106, 559-563 (1998).
19. Miltenburg AM, van Laar JM, de Kuiper R et al.: Interleukin-6 activity in paired samples of synovial fluid. Correlation of synovial fluid interleukin-6 levels with clinical and laboratory parameters of inflammation. Br. J. Rheumatol. 30, 186-189 (1991).
20. Danis VA, Franic GM, Rathjen DA et al.: Circulating cytokine levels in patients with rheumatoid arthritis: Results of a double blind trial with sulphasalazine. Ann. Rheum. Dis. 51, 946-950 (1992).
21. Dasgupta B, Corkill M, Kirkham B et al.: Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis. J. Rheumatol. 19, 22-25 (1992).
22. Arvidson NG, Gudbjornsson B, Elfman L et al.: Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann. Rheum. Dis. 53, 521-524 (1994).
23. Crofford LJ, Kalogeras KT, Mastorakos G et al.: Circadian relationships between interleukin (IL)-6 and hypothalamic- pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 82, 1279-1283 (1997).
24. Straub RH, Cutolo M: Circadian rhythms in rheumatoid arthritis. Arthritis Rheum. 56, 399-408 (2005).
25. Perry M, Jessop DS, Hunt LP, Kirwan JR: Overnight variations in cortisol, interleukin-6, tumor necrosis factor-a and other cytokines in people with rheumatoid arthritis. Ann. Rheum. Dis. 68, 63-68 (2009).
26. Perry MG, Richards L, Harbuz MS et al.: Sequential synovial fluid sampling suggests plasma and synovial fluid IL-6 vary independently in rheumatoid arthritis. Rheumatology (Oxford) 45, 229-230 (2006).
27. Arnett FC, Edworthy SM, Bloch DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324 (1988).
28. Pfohl B, Sherman B, Schlechte J, Winokur G: Differences in plasma ACTH and cortisol between depressed patients and normal controls. Biol. Psychiatry 20, 1055-1072 (1985).
29. Vgontzas AN, Zoumakis M, Bixler EO et al.: Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: Physiologic and therapeutic implications. J. Clin. Endocrinol. Metab. 88, 2087-2095 (2003).
30. Redwine L, Hauger RL, Gillin JC et al.: Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J. Clin. Endocrinol. Metab. 85, 3597-3603 (2000).
31. Vgontzas AN, Papanicolaou DA, Bixler EO et al.: Circadian interleukin-6 secretion and quantity and depth of sleep. J. Clin. Endocrinol. Metab. 84, 2603-2607 (1999).
32. Nordahl S, Alstergren P, Kopp S: Tumor necrosis factor-a in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain. J. Oral Maxillofac. Surg. 58, 525-530 (2000).
33. Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell 85, 307-310 (1996).
34. Buttgereit F, Doering G, Schaeffler A et al.: Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): A double-blind, randomised controlled trial. Lancet 371(9608), 205-214 (2008).